Supernus Pharmaceuticals, Inc.SUPNNASDAQ
LOADING
|||
Net Income Scaling
Trending higher, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$73.86M
Near historical average
Average (9y)
$70.28M
Historical baseline
Range
High:$126.95M
Low:$1.32M
CAGR
+20.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $73.86M | +5512.8% |
| 2023 | $1.32M | -97.8% |
| 2022 | $60.71M | +13.6% |
| 2021 | $53.42M | -57.9% |
| 2020 | $126.95M | +12.3% |
| 2019 | $113.06M | +1.9% |
| 2018 | $110.99M | +93.8% |
| 2017 | $57.28M | -37.2% |
| 2016 | $91.22M | +550.8% |
| 2015 | $14.02M | - |